The United States Anti-Doping Agency (USADA) has announced that Adam Bergman has received a two year suspension for testing positive to r-EPO. The 24 year old tested positive for the drug at an out-of-competition test conducted by USADA on April 6, 2004, just before the 2004 Tour de Georgia.
"The CAS Panel's decision affirms the efforts of the UCLA Laboratory and USADA to use advanced scientific methods to continue to narrow the gap between those who dope and those committed to upholding the rights of clean athletes to participate on a level playing field," said Terry Madden, USADA's chief executive officer, in a statement.
Bergman received a two-year suspension to take effect on the day following the decision but will receive credit for the time he accepted and served a provisional suspension. Therefore, his suspension will end on July 22, 2006. Additionally, Bergman forfeits all competitive results and winnings since April 6, 2004, the date of the test, including his 11th place finish in the Tour de Georgia on April 25, 2004; his fifth place finish in the U.S. Cycling Federation Elite Men's National Time Trial Championship on June 17, 2004; and his second place finish at the 2004 Olympic Trials on June 19, 2004.